KBP Biosciences Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
37
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
KBP Biosciences General Information
Description
Operator of a biotechnology research and development company intended to treat cardiovascular, respiratory, inflammatory, and autoimmune diseases. The company's platform integrates a proprietary compound library in areas of unmet medical needs and combines expertise in organ-specific disease models and a proprietary microbial bank, enabling researchers and healthcare professionals to access advanced therapeutic innovations, improving global health outcomes.
Contact Information
Website
www.kbpbio.comCorporate Office
- 10 Anson Road
- Number 17-26
- Singapore, 079903
- Singapore
Corporate Office
- 10 Anson Road
- Number 17-26
- Singapore, 079903
- Singapore
KBP Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 01-Jan-2021 | Completed | Clinical Trials - Phase 3 | |||
| 1. Later Stage VC (Series A) | 05-Jan-2018 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
KBP Biosciences Comparisons
Industry
Financing
Details
KBP Biosciences Competitors (31)
One of KBP Biosciences’s 31 competitors is Relay Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Relay Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Mission Therapeutics | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| Vividion Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| Protagonist Therapeutics | Formerly VC-backed | Newark, CA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA |
KBP Biosciences Patents
KBP Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020177658-A1 | Method for preparing tricyclic compound, and intermediate thereof | Inactive | 01-Mar-2019 | ||
| CA-3090833-A1 | Compound acting as antibiotics | Active | 10-Feb-2018 | ||
| EP-3750881-A1 | Compound acting as antibiotics | Pending | 10-Feb-2018 | ||
| EP-3750881-A4 | Compound acting as antibiotics | Pending | 10-Feb-2018 | ||
| US-11498909-B2 | Compound acting as antibiotics | Active | 10-Feb-2018 | C07D307/16 |
KBP Biosciences Signals
KBP Biosciences Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| HM Venture Partners | Venture Capital | Minority | ||
| SDIC Venture Capital | Venture Capital | Minority |
KBP Biosciences FAQs
-
When was KBP Biosciences founded?
KBP Biosciences was founded in 2007.
-
Where is KBP Biosciences headquartered?
KBP Biosciences is headquartered in Singapore, Singapore.
-
What is the size of KBP Biosciences?
KBP Biosciences has 37 total employees.
-
What industry is KBP Biosciences in?
KBP Biosciences’s primary industry is Drug Discovery.
-
Is KBP Biosciences a private or public company?
KBP Biosciences is a Private company.
-
What is KBP Biosciences’s current revenue?
The current revenue for KBP Biosciences is .
-
How much funding has KBP Biosciences raised over time?
KBP Biosciences has raised $76M.
-
Who are KBP Biosciences’s investors?
HM Venture Partners and SDIC Venture Capital have invested in KBP Biosciences.
-
Who are KBP Biosciences’s competitors?
Relay Therapeutics, Mission Therapeutics, Vividion Therapeutics, Protagonist Therapeutics, and Xenetic Biosciences are some of the 31 competitors of KBP Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process